AHMAD KHAN: Open Payments
NPI 1629065404 · STURTEVANT, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,065 in 166 payments from 18 companies in 2025. Trend: 2023 $1,431 · 2024 $2,407 · 2025 $3,065
Food & beverage: $3,048Education: $17
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 24 | $482 |
| Neurocrine BioSciences, Inc. | 22 | $475 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $293 |
| Almatica Pharma LLC | 12 | $281 |
| Janssen Pharmaceuticals, Inc | 13 | $271 |
| Otsuka America Pharmaceutical, Inc. | 13 | $225 |
| ABBVIE INC. | 11 | $189 |
| Lundbeck LLC | 11 | $173 |
| Vanda Pharmaceuticals Inc. | 12 | $160 |
| Axsome Therapeutics, Inc. | 7 | $159 |
Products named: ARISTADA, INGREZZA, REXULTI, CAPLYTA, LOREEV XR, VRAYLAR, INVEGA SUSTENNA, FANAPT.
Industry payments across WI — which companies pay providers there.
